Literature DB >> 26634745

Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.

Kun Song1, Ning Liu2, Yan Yang3, Xue Qiu4.   

Abstract

Osteopontin (OPN) is a phosphorylated glycoprotein that plays a critical role in the invasion of osteosarcoma (OS), the most common primary malignant bone tumor. Since microRNAs (miRNAs) have been well documented as key players in the tumorigenesis, cancer cell growth, and metastases, determination of the involved miRNAs that may regulate OPN-mediated OS cell invasion appears to be one important question in the current understanding and therapeutic strategies for OS. Here, we found that the levels of miR-4262 were significantly decreased and the levels of OPN were significantly increased in OS specimens, compared to the paired adjacent non-tumor tissue. Moreover, miR-4262 and OPN inversely correlated in OS specimens. The 5-year survival of the patients with lower miR-4262 levels in the resected OS was worse than that of patients with high miR-4262 levels. Bioinformatics analyses showed that miR-4262 targeted the 3'-UTR of OPN mRNA to inhibit its translation, which was proved by luciferase reporter assay. Furthermore, miR-4262 overexpression inhibited OPN-mediated cell invasion, while miR-4262 depletion increased OPN-mediated cell invasion in OS cells, in both a transwell cell invasion assay and a scratch wound healing assay. Together, our data suggest that suppression of miR-4262 in OS cells may promote OPN-mediated cancer invasion, highlighting miR-4262 as an intriguing therapeutic target to prevent OS metastases.

Entities:  

Keywords:  Cancer cell invasion; Osteopontin (OPN); Osteosarcoma (OS); miR-4262

Mesh:

Substances:

Year:  2015        PMID: 26634745     DOI: 10.1007/s13277-015-4530-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.

Authors:  Jinchang Lu; Guohui Song; Qinglian Tang; Changye Zou; Feng Han; Zhiqiang Zhao; Bicheng Yong; Junqiang Yin; Huaiyuan Xu; Xianbiao Xie; Tiebang Kang; YingLee Lam; Huiling Yang; Jingnan Shen; Jin Wang
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

2.  Two established in vitro cell lines from human mesenchymal tumours.

Authors:  J Pontén; E Saksela
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

3.  MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.

Authors:  Fei Wang; Weizhong Xiao; Jiyong Sun; Donghua Han; Youhou Zhu
Journal:  Tumour Biol       Date:  2014-05-28

4.  MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.

Authors:  Gang Liu; Chuanshen Jiang; Dazhou Li; Rong Wang; Wen Wang
Journal:  Tumour Biol       Date:  2014-07-01

Review 5.  Osteopontin: role in cell signaling and cancer progression.

Authors:  Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Journal:  Trends Cell Biol       Date:  2006-01-10       Impact factor: 20.808

Review 6.  The functional and clinical roles of osteopontin in cancer and metastasis.

Authors:  K A Furger; R K Menon; A B Tuck; V H Bramwell; A F Chambers
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

Review 7.  Osteopontin as a target for cancer therapy.

Authors:  Nicholas I F Johnston; Vignesh Kumar Gunasekharan; Amod Ravindranath; Ciara O'Connell; Patrick G Johnston; Mohamed K El-Tanani
Journal:  Front Biosci       Date:  2008-05-01

8.  Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.

Authors:  Maya Kansara; Michael Tsang; Laurent Kodjabachian; Natalie A Sims; Melanie K Trivett; Mathias Ehrich; Alexander Dobrovic; John Slavin; Peter F M Choong; Paul J Simmons; Igor B Dawid; David M Thomas
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

9.  Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

Authors:  A E S Simões; D M Pereira; S E Gomes; H Brito; T Carvalho; A French; R E Castro; C J Steer; S N Thibodeau; C M P Rodrigues; P M Borralho
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

10.  Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.

Authors:  Qiang Mei; Fang Li; Hongyu Quan; Yunlai Liu; Haidong Xu
Journal:  Cancer Sci       Date:  2014-07-03       Impact factor: 6.716

View more
  14 in total

1.  miR-4262 regulates chondrocyte viability, apoptosis, autophagy by targeting SIRT1 and activating PI3K/AKT/mTOR signaling pathway in rats with osteoarthritis.

Authors:  Wencai Sun; Yintai Li; Suizhuan Wei
Journal:  Exp Ther Med       Date:  2017-11-06       Impact factor: 2.447

2.  Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq.

Authors:  Lin Xie; Yedan Liao; Lida Shen; Fengdi Hu; Sunlin Yu; Yonghong Zhou; Ya Zhang; Yihao Yang; Dongqi Li; Minyan Ren; Zhongqin Yuan; Zuozhang Yang
Journal:  Oncotarget       Date:  2017-06-27

Review 3.  What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?

Authors:  Gaia Palmini; Francesca Marini; Maria Luisa Brandi
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

4.  miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer.

Authors:  Hongzhi Zhang; Huijuan Jiang; Huixiang Zhang; Juncai Liu; Xigang Hu; Lei Chen
Journal:  Onco Targets Ther       Date:  2019-01-15       Impact factor: 4.147

Review 5.  Osteopontin as a biomarker for osteosarcoma therapy and prognosis.

Authors:  Xingwen Han; Wenji Wang; Jingjing He; Lei Jiang; Xun Li
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

6.  Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.

Authors:  Hongwen Sun; Xiaoting Zhou; Yanan Bao; Guosheng Xiong; Yue Cui; Hua Zhou
Journal:  Open Biol       Date:  2019-07-24       Impact factor: 6.411

7.  Osteopontin in Bone Metabolism and Bone Diseases.

Authors:  Jinyan Si; Chaowei Wang; Denghui Zhang; Bo Wang; Yi Zhou
Journal:  Med Sci Monit       Date:  2020-01-30

8.  CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.

Authors:  Lu Ren; Shaoqin Yang; Qinxue Cao; Jun Tian
Journal:  Onco Targets Ther       Date:  2021-01-13       Impact factor: 4.147

9.  Correlation between Serum Osteopontin and miR-181a Levels in Allergic Rhinitis Children.

Authors:  Wenlong Liu; Qingxiang Zeng; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2016-04-21       Impact factor: 4.711

10.  MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis.

Authors:  Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Zhiwei Liu
Journal:  Oncotarget       Date:  2017-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.